AEHR and ONTO: Contrasting Paths in the AI Semiconductor Equipment Space
Key Takeaways
- AEHR is a smaller, higher-growth semiconductor test and burn-in specialist that has surged sharply in recent months on AI-related demand, trading at a premium valuation.
- ONTO is a larger, profitable process-control leader with a record backlog and stronger, more diversified revenue base.
- Both stocks benefit from AI, advanced packaging, and high-bandwidth memory (HBM) trends, but they occupy different positions in the semiconductor equipment value chain.
- AEHR is a turnaround story pivoting toward AI processors and silicon photonics; ONTO is a more established compounder with demonstrated profitability and cash generation.
- Relative performance and market positioning differ materially, with AEHR showing greater volatility and ONTO offering comparatively more earnings stability.
Why These Two Names Matter Right Now
Investors following the artificial intelligence-driven semiconductor equipment cycle often compare specialist test providers with diversified process-control companies. This comparison looks at AEHR (Aehr Test Systems) and ONTO (Onto Innovation), two companies with overlapping exposure to AI processors, advanced packaging, and HBM yet very different business models and risk profiles. Growth-oriented traders may focus on AEHR’s rapid momentum and premium valuation, while those seeking profitability and scale may prefer ONTO’s established position. I also checked this using Tickeron’s AI Screener to see how the stocks line up against industry peers. Understanding the differences in relative performance, market positioning, and catalysts helps clarify how each might fit within a diversified semiconductor portfolio.
AEHR’s Momentum and Business Shift
Aehr Test Systems, based in Fremont, California, supplies test and burn-in systems used to screen and stabilize semiconductor devices at the wafer level, in singulated die, and at the package level. In recent weeks, AEHR has been among the sector’s stronger performers, with shares climbing as investors repriced its growth outlook. The company reported record fiscal fourth-quarter bookings and a roughly $100 million effective backlog, while guiding to a significant step-up in fiscal 2027 revenue. Sentiment has been supported by a shift in revenue mix toward AI processors, silicon photonics, and power semiconductors, moving away from the electric-vehicle silicon carbide demand that previously dominated. The company also holds a strengthened cash position following an equity offering. This momentum has left the stock trading at a steep forward-sales multiple relative to its own history and industry peers.
ONTO’s Scale and Recent Results
Onto Innovation, headquartered in Wilmington, Massachusetts, provides process-control systems spanning metrology, inspection, and lithography used across the semiconductor value chain, including advanced packaging and leading-edge chip manufacturing. ONTO has posted strong recent market activity, supported by record quarterly revenue, a gross margin that expanded to roughly 57%, and a backlog exceeding $1.1 billion. Demand has been led by advanced-node metrology and inspection platforms such as the Dragonfly and Atlas families, with particular strength in 2.5D logic packaging and HBM. The company raised its second-half growth outlook and holds nearly $1.9 billion in cash and short-term investments. As with AEHR, elevated valuation multiples and customer concentration remain considerations, but ONTO’s scale, profitability, and diversified revenue base differentiate its risk profile.
Side-by-Side Comparison
The two companies serve different functions within the semiconductor supply chain. AEHR focuses on reliability screening through test and burn-in, a role that becomes more critical as AI processors and silicon photonics ramp into production. ONTO focuses on process control—measuring, inspecting, and analyzing wafers and packages to improve yield—giving it broad exposure to advanced nodes, memory, and packaging. In terms of scale, ONTO generates far higher revenue and is solidly profitable, while AEHR is transitioning from a period of losses toward a projected rebound. Growth drivers differ in intensity: AEHR’s forward guidance implies a very large year-over-year revenue increase from a small base, whereas ONTO’s growth, though strong, is more moderate in percentage terms. Risk profiles also diverge—AEHR carries higher volatility and a richer valuation multiple, while ONTO’s principal sensitivities include customer concentration and memory-cycle timing. Market sentiment toward both remains positive, but for different reasons.
Where Tickeron’s AI Assessment Points
Based on observable factors, Tickeron’s AI would likely tilt toward ONTO on a relative basis. Its consistent trend, demonstrated profitability, record backlog, and expanding margins suggest a more stable and lower-risk trajectory than AEHR’s higher-volatility, higher-multiple turnaround. That said, AEHR offers potentially greater upside if its AI and silicon-photonics bookings translate into sustained revenue growth. The AI-driven assessment leans on trend consistency and stability rather than raw momentum, which favors ONTO while acknowledging that AEHR’s catalysts could narrow the gap under favorable execution. I also looked at Tickeron’s AI Trend Prediction Engine for additional context on both names.
Exploring Tickeron’s Trending AI Robots
When reviewing momentum names such as these, I often browse Tickeron’s Trending AI Robots page to see which automated strategies are performing well in the current environment. The section highlights a curated selection of AI trading bots, each with its own style, timeframe, and performance statistics. This can provide a data-driven perspective on navigating stocks like AEHR and ONTO without relying solely on manual analysis.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
AEHR in downward trend: 10-day moving average moved below 50-day moving average on October 09, 2026
The 10-day moving average for AEHR crossed bearishly below the 50-day moving average on October 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 16 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AEHR as a result. In 75 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
The Moving Average Convergence Divergence Histogram (MACD) for AEHR turned negative on October 07, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 37 similar instances when the indicator turned negative. In 31 of the 37 cases the stock turned lower in the days that followed. This puts the odds of success at 84%.
AEHR moved below its 50-day moving average on October 06, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AEHR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
Bullish Trend Analysis
The RSI Indicator entered the oversold zone -- be on the watch for AEHR's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +7.62% 3-day Advance, the price is estimated to grow further. Considering data from situations where AEHR advanced for three days, in 245 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.
AEHR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 208 of 226 cases where AEHR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. AEHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 53 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 68, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is 66 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 69 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (14.663) is normal, around the industry mean (8.078). P/E Ratio (19.449) is within average values for comparable stocks, (161.623). Projected Growth (PEG Ratio) (0.927) is also within normal values, averaging (0.801). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (51.813) is also within normal values, averaging (27.897).
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of burn-in and test equipment for semiconductor manufacturing
Industry ElectronicProductionEquipment
Advertisement